Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CDLX
CDLX logo

CDLX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cardlytics Inc (CDLX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
5.200
1 Day change
4.21%
52 Week Range
32.800
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Cardlytics Inc (CDLX) is not a strong buy for a beginner, long-term investor at this time. The stock lacks positive momentum, has bearish technical indicators, and does not have any recent positive news or financial data to support a strong entry point. Additionally, insider selling and a downgraded analyst price target signal caution. While hedge funds are buying, the overall sentiment does not align with a strong buy recommendation.

Technical Analysis

The MACD is slightly positive at 0.00812, indicating weak bullish momentum, but the RSI at 39.899 is neutral. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading below key pivot levels (Pivot: 5.37, Current Price: 5.045). Support levels are at 4.644 and 4.196, suggesting potential downside risk.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
1

Positive Catalysts

  • Hedge funds have significantly increased their buying activity by 361.26% over the last quarter.

Neutral/Negative Catalysts

  • Insiders are selling, with a 171.74% increase in selling activity over the last month. Analysts have downgraded the price target to $1 from $1.25, citing stabilization but no clear turnaround. No recent news or congress trading data to support the stock.

Financial Performance

No financial data available for analysis. Error in retrieving the latest quarter financials.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Lake Street downgraded the price target to $1 and maintained a Hold rating, citing early signs of stabilization but no significant progress yet.

Wall Street analysts forecast CDLX stock price to fall
4 Analyst Rating
Wall Street analysts forecast CDLX stock price to fall
0 Buy
3 Hold
1 Sell
Hold
Current: 4.990
sliders
Low
1.5
Averages
1.63
High
2
Current: 4.990
sliders
Low
1.5
Averages
1.63
High
2
Lake Street
Hold
downgrade
$1
AI Analysis
2026-05-08
Reason
Lake Street
Price Target
$1
AI Analysis
2026-05-08
downgrade
Hold
Reason
Lake Street lowered the firm's price target on Cardlytics to $1 from $1.25 and keeps a Hold rating on the shares. Q1 results appeared to show stabilization and early signs of execution, says the analyst, who adds "we are not there yet, but Q1 signs are encouraging."
Evercore ISI
In Line
downgrade
$2 -> $1
2026-03-06
Reason
Evercore ISI
Price Target
$2 -> $1
2026-03-06
downgrade
In Line
Reason
Evercore ISI lowered the firm's price target on Cardlytics to $1 from $2 and keeps an In Line rating on the shares following the company's Q4 report and Q1 guidance.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CDLX
Unlock Now

People Also Watch